Mobile

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II study to Assess the efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients with Cystic Fibrosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-004699-34

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to investigate whether AZD1236 shows evidence of efficacy in CF patients by: • investigation of biomarkers (MMP-9 levels and TNF-α) in induced sputum • study signs and symptoms of CF compared to placebo

Critère d'inclusion

  • Cystic fibrosis

Liens